scispace - formally typeset
A

Arnon D. Cohen

Researcher at Clalit Health Services

Publications -  412
Citations -  9549

Arnon D. Cohen is an academic researcher from Clalit Health Services. The author has contributed to research in topics: Population & Odds ratio. The author has an hindex of 41, co-authored 374 publications receiving 7913 citations. Previous affiliations of Arnon D. Cohen include University of Milan & University of Connecticut.

Papers
More filters
Journal ArticleDOI

Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study

Khalaf Kridin, +2 more
- 01 Feb 2021 - 
TL;DR: The odds of developing PG are increased by more than threefold in patients with rheumatoid arthritis, and patients with RA may be advised to avoid additional precipitating factors of PG.
Journal Article

[Treatment of onychomycosis using 40% urea with 1% bifonazole].

A. Shemer, +3 more
- 02 Feb 1992 - 
TL;DR: Treatment with 40% urea and 1% bifonazole ointment concomitantly with oral griseofulvin seemed superior to those of either of these agents alone, with full cure, partial cure and failure in group A of 22.2, 33.3 and 44.5%, respectively.
Journal ArticleDOI

Physicians’ behavior following changes in LDL cholesterol target goals

Shlomo Vinker, +5 more
- 01 Jun 2015 - 
TL;DR: It is suggested that implementation of quality indicators that are consistent with the current literature can lead to improvements that exceeds temporal trends and better achievement of target LDL-C levels ensued.
Proceedings ArticleDOI

The Lombard Effect's Influence on Automatic Speaker Verification Systems and Methods for its Compensation

Roman Goldenberg, +2 more
TL;DR: In this paper the Lombard effect's influence on speaker verification system performance is investigated and several compensation methods are proposed, including one based on robust speech features that are resistant to the LombARD effect.
Journal ArticleDOI

Association between Takayasu arteritis and ischemic heart disease: a cohort study

Mathilde Versini, +17 more
TL;DR: TA patients present an increased proportion of ischemic heart disease (IHD) and a reduced 15-years survival rate compared to controls, and a higher proportion of all-causes mortality in the TA group.